Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S Alexander

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Cell|June 17, 1988
Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophagesS P Klinken, W S Alexander, J M Adams
Molecular and Cellular Biology|April 1, 1987
Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic miceW S Alexander, J W Schrader, J M Adams
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietinS Kimura, A W Roberts, D Metcalf, et al.
Oncogene|May 1, 1989
Lymphomagenesis in E mu-myc transgenic mice can involve ras mutationsW S Alexander, O Bernard, S Cory, et al.
Archives of Neurology|July 1, 1979
Granulomatous angiitis of the CNSR Sandhu, W S Alexander, R W Hornabrook, et al.
The EMBO Journal|December 2, 1996
Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiationW S Alexander, A B Maurer, U Novak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1987
Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic miceD L Vaux, J M Adams, W S Alexander, et al.
Immunology|September 29, 2001
Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory diseaseD V Bullen, R Darwiche, D Metcalf, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2000
The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 geneD Metcalf, L Di Rago, S Mifsud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2001
Production of colony-stimulating factors and IL-5 by organs from three types of mice with inflammatory disease due to loss of the suppressor of cytokine signaling-1D Metcalf, W S Alexander, P J Ryan, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Cell|June 17, 1988
Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophagesS P Klinken, W S Alexander, J M Adams
Molecular and Cellular Biology|April 1, 1987
Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic miceW S Alexander, J W Schrader, J M Adams
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietinS Kimura, A W Roberts, D Metcalf, et al.
Oncogene|May 1, 1989
Lymphomagenesis in E mu-myc transgenic mice can involve ras mutationsW S Alexander, O Bernard, S Cory, et al.
Archives of Neurology|July 1, 1979
Granulomatous angiitis of the CNSR Sandhu, W S Alexander, R W Hornabrook, et al.
The EMBO Journal|December 2, 1996
Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiationW S Alexander, A B Maurer, U Novak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1987
Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic miceD L Vaux, J M Adams, W S Alexander, et al.
Immunology|September 29, 2001
Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory diseaseD V Bullen, R Darwiche, D Metcalf, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2000
The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 geneD Metcalf, L Di Rago, S Mifsud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2001
Production of colony-stimulating factors and IL-5 by organs from three types of mice with inflammatory disease due to loss of the suppressor of cytokine signaling-1D Metcalf, W S Alexander, P J Ryan, et al.
Pageof 9